PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
+9.39%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$96.9M
AUM Growth
+$96.9M
(+6.3%)
Cap. Flow
+$25.2K
Cap. Flow
% of AUM
0.03%
Top 10 Holdings %
Top 10 Hldgs %
34.71%
Holding
119
New
16
Increased
37
Reduced
28
Closed
8
Top Buys
| 1 |
LeMaitre Vascular
LMAT
|
$2.68M |
| 2 |
Abbott
ABT
|
$2.46M |
| 3 |
ANI Pharmaceuticals
ANIP
|
$1.1M |
| 4 |
Seagate
STX
|
$981K |
| 5 |
Deluxe
DLX
|
$962K |
Top Sells
| 1 |
TEAR
TearLab Corporation
TEAR
|
$5.53M |
| 2 |
STJ
St Jude Medical
STJ
|
$5.1M |
| 3 |
SVU
SUPERVALU Inc.
SVU
|
$1.19M |
| 4 |
Surmodics
SRDX
|
$926K |
| 5 |
NVIDIA
NVDA
|
$740K |
Sector Composition
| 1 | Healthcare | 58.22% |
| 2 | Technology | 12.59% |
| 3 | Industrials | 9.45% |
| 4 | Energy | 3.46% |
| 5 | Communication Services | 3.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Axogen
AXGN
$743M
| $6.19M | 6.38% | 592,167 -3,741 | -0.6% | -$39.1K |
|
2
NeoGenomics
NEO
$1.13B
| $4.11M | 4.24% | 520,275 -9,900 | -2% | -$78.1K |
|
|
CSII
3
DELISTED
Cardiovascular Systems, Inc.
CSII
| $3.85M | 3.97% | 136,050 +8,500 | +7% | +$240K |
|
|
4
Abbott
ABT
$231B
| $3.71M | 3.83% | 83,546 +55,471 | +198% | +$2.46M |
|
|
VYNT
5
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $3.43M | 3.54% | 836,908 -26,692 | -3% | -$109K |
|
6
Rockwell Medical
RMTI
$58.9M
| $3.04M | 3.14% | 485,433 +42,683 | +10% | +$267K |
|
|
7
LeMaitre Vascular
LMAT
$2.16B
| $2.68M | 2.76% | +108,675 | New | +$2.68M |
|
8
AtriCure
ATRC
$1.84B
| $2.63M | 2.71% | 137,217 +9,467 | +7% | +$181K |
|
9
Idexx Laboratories
IDXX
$51.8B
| $2.17M | 2.23% | 14,000 | – | – |
|
10
Pfizer
PFE
$141B
| $1.85M | 1.91% | 54,079 -200 | -0.4% | -$6.84K |
|
11
Tactile Systems Technology
TCMD
$297M
| $1.84M | 1.9% | 96,961 | – | – |
|
|
ATRS
12
DELISTED
Antares Pharma, Inc.
ATRS
| $1.71M | 1.76% | 602,000 -5,000 | -0.8% | -$14.2K |
|
13
Eli Lilly
LLY
$657B
| $1.7M | 1.75% | 20,200 +500 | +3% | +$42.1K |
|
14
Apyx Medical
APYX
$75.3M
| $1.68M | 1.74% | 630,318 -1,717 | -0.3% | -$4.59K |
|
15
Integer Holdings
ITGR
$3.78B
| $1.55M | 1.6% | 38,550 +750 | +2% | +$30.2K |
|
|
CGNT
16
DELISTED
Cogentix Medical, Inc.
CGNT
| $1.5M | 1.55% | 835,321 -86,648 | -9% | -$156K |
|
17
Microsoft
MSFT
$3.77T
| $1.5M | 1.55% | 22,810 | – | – |
|
|
ZIXI
18
DELISTED
Zix Corporation
ZIXI
| $1.35M | 1.39% | 280,889 -100 | -0% | -$481 |
|
19
AbbVie
ABBV
$372B
| $1.28M | 1.32% | 19,675 +2,150 | +12% | +$140K |
|
20
AT&T
T
$209B
| $1.25M | 1.29% | 30,062 +1,900 | +7% | +$78.9K |
|
21
Ooma
OOMA
$356M
| $1.2M | 1.23% | 120,100 +9,650 | +9% | +$96K |
|
22
Altria Group
MO
$113B
| $1.19M | 1.23% | 16,650 +500 | +3% | +$35.7K |
|
23
IRIDEX
IRIX
$22.8M
| $1.19M | 1.22% | 100,000 +3,500 | +4% | +$41.5K |
|
24
CVS Health
CVS
$92.8B
| $1.18M | 1.21% | 14,983 +3,600 | +32% | +$283K |
|
25
Aflac
AFL
$57.2B
| $1.14M | 1.18% | 15,800 +1,500 | +10% | +$109K |
|